Bills
H.R.2115

H.R.2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

Read the bill

About This Bill

This bill was introduced in the 116th Congress
This bill is primarily about health
Introduced April 8, 2019
Latest Major Action Oct. 29, 2019

Bill Sponsor

Abigail Spanberger (D-Va.)

Bill Cosponsors

5 (3 Democrats, 2 Republicans)

Bill Versions

Referred in Senate - Oct. 29, 2019
Engrossed in House - Oct. 28, 2019
Introduced in House - April 8, 2019

Bill Summary

Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 7 statements associated with H.R.2115.

See statements

Bill Actions

Date	Description
Oct. 29, 2019	Received in the Senate and Read twice and referred to the Committee on Finance.
Oct. 28, 2019	On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586). (text: CR H8516)
Oct. 28, 2019	Considered as unfinished business. (consideration: CR H8520-8521)
Oct. 28, 2019	Considered under suspension of the rules. (consideration: CR H8516-8519)
Oct. 28, 2019	The title of the measure was amended. Agreed to without objection.
Oct. 28, 2019	Motion to reconsider laid on the table Agreed to without objection.
Oct. 28, 2019	Vote in the House On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586).
Oct. 28, 2019	Considered as unfinished business.
Oct. 28, 2019	At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct. 28, 2019	DEBATE - The House proceeded with forty minutes of debate on H.R. 2115.
Oct. 28, 2019	Considered under suspension of the rules.
Oct. 28, 2019	Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
May 21, 2019	Subcommittee Hearings Held.
April 9, 2019	Referred to the Subcommittee on Health.
April 8, 2019	Referred to the.
April 8, 2019	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
April 8, 2019	Referred to the Subcommittee on Health.
April 8, 2019	Introduced in the House by Abigail Spanberger (D-Va.)

Legislators

Bills

Statements

Lobbying

Travel